戻る Agenda
Session 3. Unlocking Potential : A Status Check on Multi-Reginal Clinical Trials for Global Drug Development
Session Chair(s)
Edana Loke
Director, JAPAC Regulatory Policy and Intelligence, AbbVie Pte Ltd, Singapore, Singapore
Martin Lim, MBA, MS
Co-Founder and CEO, ONWARD Health Research, Singapore
Speaker(s)
Martin Lim, MBA, MS
Co-Founder and CEO, ONWARD Health Research, Singapore
Romi Singh, PhD
Professor of Practice, Regulatory Sciences, Northeastern University, United States
I-Chun Lai, MD, MS
Senior Director, Division of Consultation, Center for Drug Evaluation, Taiwan, Taiwan
Dona Arlinda
Clinical Research Manager, INA-CRC, Ministry of Health (MOH) Indonesia, Indonesia
Bindoo Chahal, RPh
JAPAC Regulatory Affairs, Therapeutic Area Head, AbbVie Pte. Ltd., Singapore
Indri Rooslamiati Supriadi, MS
Director of Center for Biomedical and Health Genomics and Indonesia Clinical Res, Ministry of Health of Indonesia, Indonesia
